Exploring New FDA Initiatives

March 22, 2023 8:30am

Stacy Cline Amin
Morrison Foerster
(Washington, DC)
Former Chief Counsel, U.S. FDA

Kurt R. Karst
Hyman, Phelps & McNamara, P.C. (Washington, D.C.)

This panel will discuss how the Agency—now under the leadership of Dr. Califf will move forward with new initiatives including an evolving response to COVID-19 and examine key priorities.